Dyne Therapeutics, Inc. (DYN)
NASDAQ: DYN · Real-Time Price · USD
24.44
+0.55 (2.30%)
At close: Jul 24, 2026, 4:00 PM EDT
24.44
0.00 (-0.02%)
After-hours: Jul 24, 2026, 7:39 PM EDT
Dyne Therapeutics Market Cap
Dyne Therapeutics has a market cap or net worth of $4.56 billion as of July 24, 2026. Its market cap has increased by 249.87% in one year.
Market Cap
4.56B
Enterprise Value
3.76B
1-Year Change
249.87%
Ranking
Category
Stock Price
$24.44
ChartMarket Cap Chart
Since the IPO on September 17, 2020, Dyne Therapeutics's market cap has increased from $790.90M to $4.56B, an increase of 476.55%. That is a compound annual growth rate of 34.92%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 23, 2026 | 3.95B | 22.79% |
| Dec 31, 2025 | 3.22B | 34.33% |
| Dec 31, 2024 | 2.40B | 193.72% |
| Dec 29, 2023 | 816.30M | 35.12% |
| Dec 30, 2022 | 604.12M | -0.31% |
| Dec 31, 2021 | 606.03M | -36.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Viking Therapeutics | 4.17B |
| ACADIA Pharmaceuticals | 4.16B |
| Relay Therapeutics | 4.09B |
| Parabilis Medicines | 4.06B |
| Edgewise Therapeutics | 4.06B |
| Tango Therapeutics | 3.97B |
| Arcus Biosciences | 3.80B |
| Structure Therapeutics | 3.69B |